Apellis Pharmaceuticals (APLS) was a big mover last session on higher-than-average trading volume. However, a recent trend in earnings-estimate revisions may constrain the stock's ability to continue higher in the near term, creating a cautious near-term outlook for the equity.
Apellis Pharmaceuticals (APLS) was a big mover last session on higher-than-average trading volume. However, a recent trend in earnings-estimate revisions may constrain the stock's ability to continue higher in the near term, creating a cautious near-term outlook for the equity.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.18
Ticker Sentiment
